Accelerator Fund Projects 2017-2018
Molecular Genetic Prediction of Opioid Analgesic Dosage Requirements in African-American Orthopedic Surgery Patients
Principal Investigators (PIs):
- Henry Kranzler, MD
Psychiatry - Martin Cheatle, PHD
Psychiatry
Chemical-Genomic Screening to Enable Function Precision Medicine in Hepatocellular Carcinoma
Principal Investigators (PIs):
- Terence Gade, MD, PHD
Radiology - Junwei Shi, PHD
Cancer Biology - Sarah Cherry, PHD
Microbiology
Clinical Decision Making for AML Patients Using Algorithms
Principal Investigators (PIs):
- Robert Faryabi, PHD, MSC
Cancer Biology - Michael Feldman, MD, PHD
Pathology and Labratory Medicine
Translating a Precision Medicine Approach for Treating Idiopathic Multicentric Castleman Disease into a Clinical Trial
Principal Investigator (PI):
- David Fajgenbaum, MD, MBA, MSC
Translational Medicine and Human Genetics
Translating Targeted Cellular Immunotherapies for Autoimmune Disease to Clinical Practice
Principal Investigators (PIs):
- Aimee S. Payne, MD, PHD
Dermatology - Mike Milone, MD, PHD
Pathology and Laboratory Medicine
Advancing Diagnostic Precision in Patients with Non-Ischemic Cardiomyopathy
Principal Investigators (PIs):
- Kenneth Margulies, MD
Cardiology - Francis Marchlinski, MD
Cardiology
PARPVAX: A Two Arm, Open Label Phase IB/II Trial of Maintenance Niraparib Plus Either Nivolumab or Ipilimumab in Patients with Advanced Pancreatic Cancer Who Have Achieved Durable Stability on Platinum-Based Chemotherapy
Principal Investigator (PI):
- Kim Reiss Binder, MD
Hematology/Oncology
Systematic, Automated Screening to Improve the Diagnosis and Management of Primary Aldosteronism
Principal Investigator (PI):
- Daniel Herman, MD, PHD
Pathology and Laboratory Medicine
Economics of Precision Medicine
Principal Investigator (PI):
- Genny Kanter, PhD
Medical Ethics and Health Policy
Economics of Precision Medicine
Principal Investigator (PI):
- Sara Cherry, PhD
Chemogenomic Discovery Program